X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (825) 825
Book Review (182) 182
Publication (53) 53
Book / eBook (20) 20
Book Chapter (6) 6
Conference Proceeding (1) 1
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (628) 628
humans (385) 385
tuberculosis (376) 376
antimycobacterial activity (320) 320
chemistry, medicinal (313) 313
mycobacterium tuberculosis - drug effects (305) 305
microbial sensitivity tests (266) 266
antitubercular agents - pharmacology (252) 252
mycobacterium-tuberculosis (225) 225
animals (214) 214
pharmacology & pharmacy (194) 194
tuberculosis - drug therapy (164) 164
antitubercular agents - chemistry (163) 163
antimycobacterial (161) 161
structure-activity relationship (146) 146
derivatives (141) 141
mycobacterium tuberculosis (133) 133
chemistry, organic (126) 126
antitubercular agents - chemical synthesis (125) 125
antitubercular agents (124) 124
anti-bacterial agents - pharmacology (121) 121
biochemistry & molecular biology (119) 119
in-vitro (119) 119
microbiology (117) 117
antimycobacterial agents (104) 104
antitubercular agents - therapeutic use (104) 104
analysis (96) 96
mice (94) 94
molecular structure (92) 92
drug resistance (88) 88
drugs (86) 86
female (84) 84
agents (80) 80
drug design (78) 78
infectious diseases (74) 74
inhibitors (74) 74
male (69) 69
antibiotics (63) 63
antimicrobial activity (61) 61
anti-bacterial agents - chemical synthesis (60) 60
cytotoxicity (59) 59
anti-bacterial agents - chemistry (58) 58
drug discovery (58) 58
antibacterial activity (56) 56
dose-response relationship, drug (56) 56
pulmonary tuberculosis (56) 56
chemistry, multidisciplinary (55) 55
biological evaluation (54) 54
antimycobacterial drugs (51) 51
antimycobacterial therapy (50) 50
immunology (50) 50
design (49) 49
adult (48) 48
antibacterial (48) 48
drug therapy (48) 48
plant extracts - pharmacology (46) 46
pyrazinamide (46) 46
organic chemistry (45) 45
tuberculosis, multidrug-resistant - drug therapy (45) 45
antibacterial agents (44) 44
mycobacterium - drug effects (44) 44
resistance (44) 44
drug resistance in microorganisms (43) 43
pharmacology (43) 43
isoniazid (42) 42
tuberculosis - microbiology (42) 42
chemotherapy (41) 41
health aspects (41) 41
tuberculosis, pulmonary - drug therapy (41) 41
rifampin (40) 40
anti-bacterial agents - therapeutic use (39) 39
cell line (39) 39
cell line, tumor (38) 38
ethambutol (38) 38
antitubercular activity (37) 37
bacteria (37) 37
models, molecular (37) 37
susceptibility (37) 37
antimicrobial agents (36) 36
biochemistry, general (36) 36
plant sciences (36) 36
respiratory system (36) 36
synthesis (36) 36
antitubercular agents - pharmacokinetics (35) 35
cercopithecus aethiops (35) 35
chemistry (35) 35
multidrug-resistant tuberculosis (35) 35
middle aged (34) 34
natural-products (34) 34
vero cells (34) 34
assay (33) 33
identification (33) 33
pharmacology/toxicology (33) 33
analogs (32) 32
cell biology (32) 32
discovery (32) 32
infection (32) 32
antitubercular agents - administration & dosage (31) 31
ciprofloxacin (31) 31
integrative & complementary medicine (31) 31
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (837) 837
German (9) 9
Japanese (3) 3
Spanish (3) 3
French (2) 2
Korean (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gastroenterology, ISSN 0016-5085, 2007, Volume 132, Issue 7, pp. 2313 - 2319
Journal Article
Journal Article
Frontiers in Microbiology, ISSN 1664-302X, 09/2018, Volume 9, pp. 2271 - 2271
Journal Article
Molecular Pharmaceutics, ISSN 1543-8384, 08/2015, Volume 12, Issue 8, pp. 2574 - 2581
Tuberculosis is the most serious infectious disease caused by a single organism, Mycobacterium tuberculosis (Mtb). The standard of care is a protracted and... 
pyrazinoic acid salts | antimycobacterial activity | spray drying | therapeutic aerosols | pulmonary drug delivery | tuberculosis | MYCOBACTERIUM-TUBERCULOSIS | DRUG | MEDICINE, RESEARCH & EXPERIMENTAL | TUBERCLE BACILLI | DRY POWDER | CHEMOTHERAPY | DELIVERY | PYRAZINOIC ACID | CAPREOMYCIN | PYRAZINAMIDE | PHARMACOLOGY & PHARMACY
Journal Article
Pharmaceutical Research, ISSN 0724-8741, 7/2018, Volume 35, Issue 7, pp. 1 - 11
The purpose of the study was initial evaluation of applicability of metal organic framework (MOF) Fe-MIL-101-NH2 as a theranostic carrier of antituberculous... 
Biochemistry, general | Biomedical Engineering | inhaled dosage forms | Biomedicine | tuberculosis treatment | Pharmacy | Medical Law | iron metal-organic framework (MOF) | MRI contrast agent | theranostic system | Pharmacology/Toxicology | ANTITUBERCULOSIS DRUGS | LUNG | AEROSOL DEPOSITION | DRUG-DELIVERY | CONTRAST AGENTS | MRI | NANOMEDICINE | RELEASE | CHEMISTRY, MULTIDISCIPLINARY | NANOPARTICLES | PHARMACOLOGY & PHARMACY | EFFICIENT | Cell Line | Iron - administration & dosage | Drug Carriers - metabolism | Antitubercular Agents - chemistry | Magnetic Resonance Spectroscopy - methods | Iron - chemistry | Drug Carriers - administration & dosage | Iron - metabolism | Drug Carriers - chemistry | Dose-Response Relationship, Drug | Animals | Theranostic Nanomedicine - methods | Fibroblasts - drug effects | Tuberculosis - drug therapy | Antitubercular Agents - administration & dosage | Antitubercular Agents - metabolism | Tuberculosis - metabolism | Fibroblasts - metabolism | Drugs | Drug delivery systems | Tuberculosis | Antitubercular agents | Respiratory agents | Contrast media | Vehicles | Scanning electron microscopy | Particle size | Nuclear magnetic resonance--NMR | Toxicity | X ray powder diffraction | Lung | Metals | Cytotoxicity | Iron | Drug delivery | Dissolution | Powder | Contrast agents | Spectrometry | Diffraction | Magnetic resonance imaging | Fibroblasts | Resonance | Safety | Antimycobacterial agents | Metal-organic frameworks | Isoniazid | Index Medicus | Research Paper
Journal Article
PLOS ONE, ISSN 1932-6203, 09/2018, Volume 13, Issue 9, pp. e0204495 - e0204495
New therapeutic strategies are needed to treat drug resistant tuberculosis (TB) and to improve treatment for drug sensitive TB. Pyrazinamide (PZA) is a... 
EXPERIMENTAL AIRBORNE TUBERCULOSIS | ANTIMYCOBACTERIAL ACTIVITY | PYRAZINAMIDE RESISTANCE | MURINE MODEL | IN-VITRO | STERILIZING ACTIVITY | ANTITUBERCULOSIS AGENTS | MULTIDISCIPLINARY SCIENCES | DRUG DISCOVERY | ESTERS | RESISTANT MYCOBACTERIUM-TUBERCULOSIS | Granuloma, Respiratory Tract - pathology | Tuberculosis, Pulmonary - microbiology | Granuloma, Respiratory Tract - drug therapy | Male | Tuberculosis, Pulmonary - drug therapy | Mycobacterium tuberculosis - drug effects | Necrosis | Granuloma, Respiratory Tract - microbiology | Rifampin - administration & dosage | Drug Therapy, Combination | Tuberculosis, Multidrug-Resistant - pathology | Disease Models, Animal | Pyrazinamide - administration & dosage | Dry Powder Inhalers | Guinea Pigs | Pyrazinamide - analogs & derivatives | Pyrazinamide - pharmacokinetics | Bacterial Load | Respiratory Tract Absorption | Tuberculosis, Pulmonary - pathology | Animals | Antitubercular Agents - pharmacokinetics | Aerosols | Antitubercular Agents - administration & dosage | Tuberculosis, Multidrug-Resistant - drug therapy | Drugs | Usage | Drug delivery systems | Tuberculosis | Development and progression | Dosage and administration | Drug therapy | Pyrazinamide | Health aspects | Testing | Vehicles | Spleen | Therapy | Bacilli | Liver | Infections | Drug resistance | Powder | Critical components | Medicine | Chemotherapy | Immunology | Acids | Lungs | Guinea pigs | Sterilization | Drug dosages | Rifampin | Index Medicus
Journal Article
World Journal of Gastroenterology, ISSN 1007-9327, 04/2015, Volume 21, Issue 13, pp. 4048 - 4062
Journal Article
Asian Pacific Journal of Tropical Medicine, ISSN 1995-7645, 08/2018, Volume 11, Issue 8, pp. 453 - 459
Tuberculosis (TB) is a communicable disease caused by Mycobacterium tuberculosis (M. tuberculosis). WHO estimated that 10.4 million new (incident) TB cases... 
Hybrid bacteriocin | Antimycobacterial peptides | Lactic acid bacteria | Tuberculosis | Immunomodulation | Bacteriocin | PEDIOCIN-LIKE BACTERIOCINS | IFN-GAMMA | PROBIOTICS | ANTIMICROBIAL PEPTIDES | TROPICAL MEDICINE | NISIN | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | PRECURSOR LIPID II | CHEMICAL-SYNTHESIS | MYCOBACTERIUM-BOVIS | LACTOCOCCUS-LACTIS
Journal Article
Pharmaceutical Research, ISSN 0724-8741, 10/2016, Volume 33, Issue 10, pp. 2495 - 2505
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 02/2017, Volume 61, Issue 2, p. AAC.01701-16
Journal Article
Bioorganic & Medicinal Chemistry, ISSN 0968-0896, 02/2015, Volume 23, Issue 4, pp. 868 - 875
Journal Article